Cargando…
Evidence gaps on weight gain in people living with HIV: a scoping review to define a research agenda
BACKGROUND: Combined antiretroviral therapy (cART) dramatically improved survival in people living with HIV (PLWH) but is associated with weight gain (WG), raising concern for a possible obesity epidemic in PLWH. This scoping review aims to identify the gaps in the existing evidence on WG in PLWH an...
Autores principales: | Guaraldi, Giovanni, Bonfanti, Paolo, Di Biagio, Antonio, Gori, Andrea, Milić, Jovana, Saltini, Paola, Segala, Francesco V., Squillace, Nicola, Taramasso, Lucia, Cingolani, Antonella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10103467/ https://www.ncbi.nlm.nih.gov/pubmed/37060030 http://dx.doi.org/10.1186/s12879-023-08174-3 |
Ejemplares similares
-
Weight Gain: A Possible Side Effect of All Antiretrovirals
por: Taramasso, Lucia, et al.
Publicado: (2017) -
Factors Associated With Weight Gain in People Treated With Dolutegravir
por: Taramasso, Lucia, et al.
Publicado: (2020) -
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a large observational cohort study (SCOLTA)
por: Taramasso, Lucia, et al.
Publicado: (2018) -
Dolutegravir is not associated with weight gain in antiretroviral therapy experienced geriatric patients living with HIV
por: Guaraldi, Giovanni, et al.
Publicado: (2021) -
Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project
por: Bagella, Paola, et al.
Publicado: (2019)